The Environmental Working Group published its annual “Dirty Dozen” list, which ranks fruits and vegetables by most and least contaminated with pesticide residues. Greg Sears, PerkinElmer’s VP and GM of Chromatography, Mass Spectrometry and Food, weighs in on why pesticide analysis is a critical part of today’s food ecosystem.
Recent Media Coverage
Read recent articles about PerkinElmer below. Clicking a headline will take you to the publication’s website for the full article.
Gary Harton, a member of the team focused on pre-implantation genetic testing at PerkinElmer, talks about the process for patients who undergo genetic testing for neurodegenerative diseases.
Emerald Scientific awarded the "Emerald Test" badges to PerkinElmer, affirming our instruments' ability to accurately detect pesticides, heavy metals, residual solvents, terpenes and potency in cannabis.
Optimization of experimental assay design is crucial for the overall success of any drug discovery initiative.
Dr. Linh Hoang, M.D., Ph.D., vice president of Reproductive Health, outlines why early detection of preeclamspia provides a valuable window of opportunity for vigilance and intervention.
In this "Bold Types" feature, CFO Jamey Mock highlights some of the ways PerkinElmer will look to drive future growth.
Drug development is facing change from both technological pressures, including the use of AI and machine learning, and new regulations, which are transforming the way electronic records are created and stored for clinical trials.
For cannabis and hemp analysis, the high sensitivity of the QSight 400 Series supports laboratories in meeting state and federal regulations, including California and Canada.
Monitoring of residues in food substances is critical to ensuring no products are sold that contain dangerous levels of pesticides. Testing for even the smallest amounts of contaminants requires innovative lab equipment to guarantee products meet strict regulatory requirements.
The test, designed for noninvasive prenatal screening for trisomies 21, 18, and 13, with Y chromosome testing as an optional marker, has been validated in an external clinical study in France.
David Wang, general manager of Informatics, explains how scientists can harness valuable information quickly to achieve better, faster outcomes—and expedite the drug discovery process—by taking "the 3Vs" into account.
AI comes in many forms, but machine learning and natural language processing are two which are helping drug discovery scientists find new drug candidates.
EUROIMMUN's Dr. Konstanze Stiba discusses the challenges associated with developing a diagnostic for "Disease X," which represents newly emerging pathogens that present a significant public health risk - with the potential for an international epidemic.
Sanofi Genzyme and PerkinElmer Genomics have launched a free genetic testing program that aims to spot certain undiagnosed lysosomal storage disorders, while raising awareness of the group of rare diseases whose symptoms may initially be ascribed to more common ailments.
Jamey Mock talks about the first 120 days in his role as PerkinElmer CFO.
PerkinElmer scientists are testing cannabis for pesticide and mycotoxin levels using an LC-MS/MS method.